Of paramount importance, oral treatment with UB-EV-52 increased the lifespan of Npc mice by 25% and improved weight gain, and reduced symptoms of tremor and unstable gait that were visually detectable in Npc mice at postnatal week seven without sex bias. This evidence concerns the gene NPC1 and Tremor.